Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

GNMX vs. FACDX: which is better?

Bottom line

GNMX vs FACDX: the short answer

GNMX (Corgi Genomics & Precision Medicine ETF) and FACDX (Fidelity Advisor Health Care Fund) are both etfs.

Updated Nov 19, 2026

GNMX vs FACDX side by side

GNMXFACDX
TypeETFMutual fund
Fund familyCorgi Genomics & Precision MedicineFidelity
CategoryHealth Care SectorHealth Care Sector
Expense ratio—0.96%
Annual cost per $10k—$96
10-yr cost on $10k (prospectus)—$1,685
Max front loadNone—
12b-1 fee—0.25%
1-yr return—+7.7%
5-yr return (annualized)—+2.3%
10-yr return (annualized)—+7.6%
Best quarter—+21.3%
Worst quarter—−15.0%
Net assets (fund)—$3.1B
Number of holdings—154
Portfolio turnover—74%
Returns as of—Sep 30, 2026

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

GNMX and FACDX share none of their top holdings.

GNMX top 10

    FACDX top 10

    1. ELI LILLY and CO — 7.66%
    2. Danaher Corp — 6.75%
    3. Thermo Fisher Scientific Inc — 6.31%
    4. Unitedhealth Group Inc — 4.17%
    5. JOHNSON and JOHNSON — 3.78%
    6. Abbvie Inc — 3.62%
    7. Fidelity Revere Street Trust — 2.54%
    8. Argenx Se — 2.09%
    9. MERCK and CO INC — 2.09%
    10. West Pharmaceutical Svcs Inc — 2.06%

    FAQ

    What is the difference between GNMX and FACDX?
    GNMX (Corgi Genomics & Precision Medicine ETF) and FACDX (Fidelity Advisor Health Care Fund) are both etfs.
    Should I own both GNMX and FACDX?
    Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

    Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.